Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly set to begin critical Alimta patent dispute, WSJ says
Lilly set to begin critical Alimta patent dispute, WSJ says
Lilly set to begin critical Alimta patent dispute, WSJ says
Submitted by
admin
on August 19, 2013 - 9:46am
Source:
The Fly on the Wall
News Tags:
Eli Lilly
patents
Alimta
non-small cell lung cancer
Headline:
Lilly set to begin critical Alimta patent dispute, WSJ says
Do Not Allow Advertisers to Use My Personal information
